Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Are study dropouts different from completers?
Hypochondriacal concerns in depressed outpatients.
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
The STAR*D Project results: a comprehensive review of findings.
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.
Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis.
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
Comparison of academic and nonacademic sites in multi-center clinical trials.
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial.
Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder.
When should a trial of fluoxetine for major depression be declared failed?
Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).